📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Toxicity-dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials. (2017)

First Author: Wheeler GM

Attributed to: Adaptive Clinical Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/sim.7280

PubMed Identifier: 28295513

Publication URI: http://europepmc.org/abstract/MED/28295513

Type: Journal Article/Review

Volume: 36

Parent Publication: Statistics in medicine

Issue: 16

ISSN: 0277-6715